Informa appoints Adam Andersen as Group Director Pharma Portfolio

Informa plc has appointed Adam Andersen Group Director of the Pharma Portfolio (previously part of UBM), which includes ...

October 30, 2018 | Tuesday | News
Thermo Fisher, Symphogen to simplify study of Complex Therapeutic Proteins

Thermo Fisher Scientific, the world leader in serving science, and Symphogen, a clinical-stage antibody oncology-focused...

October 30, 2018 | Tuesday | News
Bio-Rad IH-reader 24 receives FDA clearance

Singapore – The FDA grants 510(k) clearance for Bio-Rad Laboratories' IH-Reader 24, a semi-automated blo...

October 30, 2018 | Tuesday | News
Takeda offers to divest Shire drug to satisfy EU regulators

Singapore – Aimed at satisfying European Commission (EC) concerns about the potential overlap in the inflammatory ...

October 30, 2018 | Tuesday | News
EBD opens its partneringONE Platform for BIO-Europe 2018

EBD Group (EBD), the market-leading provider of world-class partnering events and tools for the global life science...

October 29, 2018 | Monday | News
Elpis human cells can replace animal experiments in Drug Discovery

Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OP...

October 26, 2018 | Friday | News
M3 biotechnology appoints leaders in Alzheimer's research, CNS drug development and clinical trial design

M3 Biotechnology, a Seattle-based therapeutics company dedicated to developing, first-in-class, therapies for Alzhe...

October 26, 2018 | Friday | News
ICON Wins Pharma Contract Services Company of the Year Award

ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and me...

October 25, 2018 | Thursday | News
Pfizer, Bain Capital create new company Cerevel Therapeutics

Bain Capital and  Pfizer have announced the creation of Cerevel Therapeutics,  a new biopharmaceutical company...

October 24, 2018 | Wednesday | News
AstraZeneca expands collaboration with Innate Pharma

AstraZeneca, and its global biologics research and development arm MedImmune, have announced a new multi-term agreement ...

October 24, 2018 | Wednesday | News
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain

Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...

October 24, 2018 | Wednesday | News
Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering

Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led b...

October 24, 2018 | Wednesday | News
Kibow Biotech to exhibit Its "Enteric Dialysis" Technology at ASN 2018

Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...

October 24, 2018 | Wednesday | News
Epilepsy Society, UCL, Congenica unite to identify cause of epileptic death

Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...

October 23, 2018 | Tuesday | News
Stream Bio expands its CPN products distribution network across Europe

Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...

October 23, 2018 | Tuesday | News
AstraZeneca's Lynparza shown to cut cancer progression by 70%

AstraZeneca and Merck  have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...

October 22, 2018 | Monday | News
FDA approves Regeneron, Sanofi's Dupixent for asthma treatment

Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...

October 22, 2018 | Monday | News
Roche's Tecentriq extends progression-free survival in TNBC

Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...

October 22, 2018 | Monday | News